Cargando…

Correction: Therapeutic Efficacy of Antibodies Lacking Fc. Receptor Binding against Lethal Dengue Virus Infection Is Due to Neutralizing Potency and Blocking of Enhancing Antibodies

Detalles Bibliográficos
Autores principales:	Williams, Katherine L., Sukupolvi-Petty, Soila, Beltramello, Martina, Johnson, Syd, Sallusto, Federica, Lanzavecchia, Antonio, Diamond, Michael S., Harris, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613268/ http://dx.doi.org/10.1371/annotation/e08f911a-15ec-46d0-bede-83fdf3af1801

Ejemplares similares

Therapeutic Efficacy of Antibodies Lacking FcγR against Lethal Dengue Virus Infection Is Due to Neutralizing Potency and Blocking of Enhancing Antibodies
por: Williams, Katherine L., et al.
Publicado: (2013)

The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1
por: Shrestha, Bimmi, et al.
Publicado: (2010)

In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection
por: de Alwis, Ruklanthi, et al.
Publicado: (2011)

Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification
por: Balsitis, Scott J., et al.
Publicado: (2010)

Correction: In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection
por: de Alwis, Ruklanthi, et al.
Publicado: (2011)

Rational Engineering of a Human Anti-Dengue Antibody through Experimentally Validated Computational Docking
por: Simonelli, Luca, et al.
Publicado: (2013)

Development of an in Vitro Potency Assay for Anti-anthrax Lethal Toxin Neutralizing Antibodies
por: Whiting, Gail, et al.
Publicado: (2012)

The Potent and Broadly Neutralizing Human Dengue Virus-Specific Monoclonal Antibody 1C19 Reveals a Unique Cross-Reactive Epitope on the bc Loop of Domain II of the Envelope Protein
por: Smith, Scott A., et al.
Publicado: (2013)

Neutralizing antibodies protect mice against Venezuelan equine encephalitis virus aerosol challenge
por: Kafai, Natasha M., et al.
Publicado: (2022)

Rational engineering of Fc/Fc receptor interactions to improve antibody potency
por: Doberstein, S, et al.
Publicado: (2003)

Human monoclonal antibodies by immortalization of memory B cells
por: Lanzavecchia, Antonio, et al.
Publicado: (2007)

prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis
por: A. Dowd, Kimberly, et al.
Publicado: (2023)

IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody
por: Richardson, Simone I., et al.
Publicado: (2019)

HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector Function
por: Richardson, Simone I., et al.
Publicado: (2021)

Boosting therapeutic potency of antibodies by taming Fc domain functions
por: Kang, Tae Hyun, et al.
Publicado: (2019)

Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors: Fc-mediated avidity enhances the potency of an anti-TLR4 antibody
por: Loyau, Jérémy, et al.
Publicado: (2014)

Potent Dengue Virus Neutralization by a Therapeutic Antibody with Low Monovalent Affinity Requires Bivalent Engagement
por: Edeling, Melissa A., et al.
Publicado: (2014)

Structural basis of West Nile virus neutralization by a therapeutic antibody
por: Nybakken, Grant E., et al.
Publicado: (2005)

Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses
por: Radić, Laura, et al.
Publicado: (2023)

Role of Homologous Fc Fragment in the Potency and Efficacy of Anti-Botulinum Antibody Preparations
por: Torgeman, Amram, et al.
Publicado: (2017)

110 Broadly neutralizing antibodies for serotherapy and vaccine design
por: Lanzavecchia, Antonio
Publicado: (2014)

Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection
por: Collins, Matthew H., et al.
Publicado: (2017)

Neutralizing antibodies against Mayaro virus require Fc effector functions for protective activity
por: Earnest, James T., et al.
Publicado: (2019)

Equal Neutralization Potency of Antibodies Raised against Abrin Subunits
por: Gal, Yoav, et al.
Publicado: (2020)

Tackling influenza with broadly neutralizing antibodies
por: Corti, Davide, et al.
Publicado: (2017)

Dengue virus infection-enhancement activity in neutralizing antibodies of healthy adults before dengue season as determined by using FcγR-expressing cells
por: Ly, Minh Huong Phu, et al.
Publicado: (2018)

Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement
por: Fink, Ashley L., et al.
Publicado: (2017)

Increased half-life and enhanced potency of Fc-modified human PCSK9 monoclonal antibodies in primates
por: Shen, Yijun, et al.
Publicado: (2017)

Neutralizing Antibodies after Infection with Dengue 1 Virus
por: Guzman, Maria G., et al.
Publicado: (2007)

Broad dengue neutralization in mosquitoes expressing an engineered antibody
por: Buchman, Anna, et al.
Publicado: (2020)

Antibody affinity versus dengue morphology influences neutralization
por: Fibriansah, Guntur, et al.
Publicado: (2021)

Engineering pan–HIV-1 neutralization potency through multispecific antibody avidity
por: Rujas, Edurne, et al.
Publicado: (2022)

Dengue Virus Neutralization in Cells Expressing Fc Gamma Receptors
por: Chawla, Tanu, et al.
Publicado: (2013)

Therapeutic Administration of Broadly Neutralizing FI6 Antibody Reveals Lack of Interaction Between Human IgG1 and Pig Fc Receptors
por: Morgan, Sophie B., et al.
Publicado: (2018)

A requirement for FcγR in antibody-mediated bacterial toxin neutralization
por: Abboud, Nareen, et al.
Publicado: (2010)

Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
por: Parsons, Matthew S., et al.
Publicado: (2018)

Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization
por: Su, Bin, et al.
Publicado: (2019)

NMDA-receptor-Fc-fusion constructs neutralize anti-NMDA receptor antibodies
por: Steinke, Stephan, et al.
Publicado: (2023)

Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineering
por: Heckel, Franziska, et al.
Publicado: (2022)

Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope
por: Austin, S. Kyle, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_v0u6iuk0i16bodu6pvoot32qsb